Evidence map›Paper›PMID 29584451›Full record

ArticleAmerican journal of respiratory cell and molecular biology2018

Epithelial Heparan Sulfate Contributes to Alveolar Barrier Function and Is Shed during Lung Injury.

Sarah M Haeger, Xinyue Liu, Xiaorui Han, J Brennan McNeil, Kaori Oshima, Sarah A McMurtry, Yimu Yang, Yilan Ouyang, Fuming Zhang, Eva Nozik-Grayck and 5 more

Abstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Endothelial glycocalyx glycan expression in lymphatic vasculature in mice.Frontiers in cell and developmental biology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Enzymatic Modulation of the Pulmonary Glycocalyx Enhances Susceptibility toAmerican journal of respiratory cell and molecular biology · 2024
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Liraglutide pretreatment attenuates sepsis-induced acute lung injury.American journal of physiology. Lung cellular and molecular physiology · 2023
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Sarah M Haeger1 Department of Medicine and.
Xinyue Liu2 Department of Chemistry, Rensselaer Polytechnic Institute, Troy, New York.
Xiaorui Han2 Department of Chemistry, Rensselaer Polytechnic Institute, Troy, New York.
J Brennan McNeil3 Department of Medicine, Vanderbilt University, Nashville, Tennessee.
Kaori Oshima1 Department of Medicine and.
Sarah A McMurtry1 Department of Medicine and.
Yimu Yang1 Department of Medicine and.
Yilan Ouyang2 Department of Chemistry, Rensselaer Polytechnic Institute, Troy, New York.
Fuming Zhang2 Department of Chemistry, Rensselaer Polytechnic Institute, Troy, New York.
Eva Nozik-Grayck4 Department of Pediatrics, University of Colorado Denver, Aurora, Colorado.
Rachel L Zemans5 Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan; and.
Rubin M Tuder1 Department of Medicine and.
Julie A Bastarache3 Department of Medicine, Vanderbilt University, Nashville, Tennessee.
Robert J Linhardt2 Department of Chemistry, Rensselaer Polytechnic Institute, Troy, New York.
Eric P Schmidt1 Department of Medicine and.
Rensselaer Polytechnic Institute · USVanderbilt University · USDenver Health Medical Center · USMichigan Medicine · USUniversity of Colorado Denver · US

Funding

PREDOCTORAL TRAINING PROGRAM IN PHARMACOLOGYT32GM007635 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI DELL'ACQUA, MARK L · 1985 to 2023
$6.1M
Impact of Insufficient Vascular EC-SOD in Pulmonary HypertensionR01HL086680 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI NOZIK, EVA S. · 2008 to 2017
$4.7M
SOD3 regulation of redox sensitive signaling in pulmonary vascular diseasesR35HL139726 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI NOZIK, EVA S. · 2018 to 2024
$4.1M
Endothelial glycocalyx reconstitution during sepsisR01HL125371 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI LINHARDT, ROBERT J, SCHMIDT, ERIC PETER · 2014 to 2018
$3.4M
Mechanisms of Repair of the Alveolar Epithelium after Lung InjuryR01HL131608 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ZEMANS, RACHEL LYNNE · 2016 to 2020
$1.9M
Heparan Sulfate Fragments and Lung RepairF30HL132424 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI HAEGER, SARAH MARIE · 2016 to 2018
$116k
NHLBI NIH HHS F30 HL132424NHLBI NIH HHS R01 HL086680NHLBI NIH HHS R01 HL125371NHLBI NIH HHS R01 HL131608NHLBI NIH HHS R35 HL139726NIGMS NIH HHS T32 GM007635
6 · The paper itself

Abstract

The lung epithelial glycocalyx is a carbohydrate-enriched layer lining the pulmonary epithelial surface. Although epithelial glycocalyx visualization has been reported, its composition and function remain unknown. Using immunofluorescence and mass spectrometry, we identified heparan sulfate (HS) and chondroitin sulfate within the lung epithelial glycocalyx. In vivo selective enzymatic degradation of epithelial HS, but not chondroitin sulfate, increased lung permeability. Using mass spectrometry and gel electrophoresis approaches to determine the fate of epithelial HS during lung injury, we detected shedding of 20 saccharide-long or greater HS into BAL fluid in intratracheal LPS-treated mice. Furthermore, airspace HS in clinical samples from patients with acute respiratory distress syndrome correlated with indices of alveolar permeability, reflecting the clinical relevance of these findings. The length of HS shed during intratracheal LPS-induced injury (≥20 saccharides) suggests cleavage of the proteoglycan anchoring HS to the epithelial surface, rather than cleavage of HS itself. We used pharmacologic and transgenic animal approaches to determine that matrix metalloproteinases partially mediate HS shedding during intratracheal LPS-induced lung injury. Although there was a trend toward decreased alveolar permeability after treatment with the matrix metalloproteinase inhibitor, doxycycline, this did not reach statistical significance. These studies suggest that epithelial HS contributes to the lung epithelial barrier and its degradation is sufficient to increase lung permeability. The partial reduction of HS shedding achieved with doxycycline is not sufficient to rescue epithelial barrier function during intratracheal LPS-induced lung injury; however, whether complete attenuation of HS shedding is sufficient to rescue epithelial barrier function remains unknown.

Indexed as

AnimalsCapillary PermeabilityEndothelium, VascularGlycocalyxHeparan SulfateLipopolysaccharidesLung InjuryMiceRespiratory Distress SyndromeSyndecansHeparan Sulfatelipopolysaccharide ALipopolysaccharidesSyndecansacute respiratory distress syndromeepithelial glycocalyxheparan sulfatesyndecan

Identifiers

PMID29584451
PMCPMC6189644
OpenAlexW2794481632

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.